Eledon Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
25.40
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.68
|
-0.73
|
-0.05
|
-7.35%
|
|
2022-06-30
|
-0.70
|
-0.65
|
0.05
|
7.14%
|
|
2022-03-31
|
-0.68
|
-0.69
|
-0.01
|
-1.47%
|
|
2021-12-31
|
-0.75
|
-0.59
|
0.16
|
21.33%
|
|
2021-09-30
|
-0.65
|
-0.66
|
-0.01
|
-1.54%
|
|
2021-06-30
|
-0.57
|
-0.50
|
0.07
|
12.28%
|
|
2021-03-31
|
-0.32
|
-0.57
|
-0.25
|
-78.13%
|
|
2020-12-31
|
-1.39
|
-2.12
|
-0.73
|
-52.52%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.07
|
|
2021-12-31
|
-2.32
|
|
2020-12-31
|
-18.79
|
|
2019-12-31
|
-25.38
|
|
2018-12-31
|
-26.46
|
|
2016-12-31
|
-15.21
|
|
2015-12-31
|
-13.37
|
|
2014-12-31
|
-2.99
|